vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and BLACKLINE, INC. (BL). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $183.2M, roughly 2.0× BLACKLINE, INC.). BLACKLINE, INC. runs the higher net margin — 2.7% vs -0.8%, a 3.4% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 8.1%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $26.1M). Over the past eight quarters, BLACKLINE, INC.'s revenue compounded faster (7.9% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
ASIX vs BL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $183.2M |
| Net Profit | $-2.8M | $4.9M |
| Gross Margin | 7.6% | 75.2% |
| Operating Margin | -0.7% | 3.7% |
| Net Margin | -0.8% | 2.7% |
| Revenue YoY | 9.4% | 8.1% |
| Net Profit YoY | -892.9% | -91.3% |
| EPS (diluted) | $-0.11 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $183.2M | ||
| Q3 25 | $374.5M | $178.3M | ||
| Q2 25 | $410.0M | $172.0M | ||
| Q1 25 | $377.8M | $166.9M | ||
| Q4 24 | $329.1M | $169.5M | ||
| Q3 24 | $398.2M | $165.9M | ||
| Q2 24 | $453.5M | $160.5M | ||
| Q1 24 | $336.8M | $157.5M |
| Q4 25 | $-2.8M | $4.9M | ||
| Q3 25 | $-2.6M | $5.3M | ||
| Q2 25 | $31.4M | $8.3M | ||
| Q1 25 | $23.3M | $6.1M | ||
| Q4 24 | $352.0K | $56.4M | ||
| Q3 24 | $22.3M | $17.2M | ||
| Q2 24 | $38.9M | $76.7M | ||
| Q1 24 | $-17.4M | $10.8M |
| Q4 25 | 7.6% | 75.2% | ||
| Q3 25 | 6.8% | 75.1% | ||
| Q2 25 | 14.3% | 75.2% | ||
| Q1 25 | 14.2% | 75.5% | ||
| Q4 24 | 3.4% | 75.6% | ||
| Q3 24 | 14.4% | 75.2% | ||
| Q2 24 | 17.9% | 74.9% | ||
| Q1 24 | 0.9% | 75.2% |
| Q4 25 | -0.7% | 3.7% | ||
| Q3 25 | -0.9% | 4.3% | ||
| Q2 25 | 7.7% | 4.4% | ||
| Q1 25 | 7.7% | 2.1% | ||
| Q4 24 | -3.9% | 3.7% | ||
| Q3 24 | 7.5% | 5.0% | ||
| Q2 24 | 11.5% | 1.4% | ||
| Q1 24 | -7.0% | 1.1% |
| Q4 25 | -0.8% | 2.7% | ||
| Q3 25 | -0.7% | 3.0% | ||
| Q2 25 | 7.7% | 4.8% | ||
| Q1 25 | 6.2% | 3.6% | ||
| Q4 24 | 0.1% | 33.3% | ||
| Q3 24 | 5.6% | 10.4% | ||
| Q2 24 | 8.6% | 47.8% | ||
| Q1 24 | -5.2% | 6.9% |
| Q4 25 | $-0.11 | $0.07 | ||
| Q3 25 | $-0.10 | $0.09 | ||
| Q2 25 | $1.15 | $0.13 | ||
| Q1 25 | $0.86 | $0.10 | ||
| Q4 24 | $0.02 | $0.79 | ||
| Q3 24 | $0.82 | $0.27 | ||
| Q2 24 | $1.43 | $0.22 | ||
| Q1 24 | $-0.65 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $390.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $332.3M |
| Total Assets | $1.7B | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $390.0M | ||
| Q3 25 | $23.7M | $419.9M | ||
| Q2 25 | $18.4M | $459.1M | ||
| Q1 25 | $8.3M | $479.5M | ||
| Q4 24 | $19.6M | $885.9M | ||
| Q3 24 | $17.3M | $725.3M | ||
| Q2 24 | $12.1M | $616.6M | ||
| Q1 24 | $20.6M | $331.4M |
| Q4 25 | $815.2M | $332.3M | ||
| Q3 25 | $818.2M | $328.3M | ||
| Q2 25 | $823.7M | $414.0M | ||
| Q1 25 | $794.4M | $417.9M | ||
| Q4 24 | $774.6M | $446.7M | ||
| Q3 24 | $766.4M | $367.9M | ||
| Q2 24 | $746.6M | $325.8M | ||
| Q1 24 | $713.2M | $279.8M |
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.6B | $1.8B | ||
| Q1 25 | $1.6B | $1.8B | ||
| Q4 24 | $1.6B | $1.8B | ||
| Q3 24 | $1.5B | $1.7B | ||
| Q2 24 | $1.5B | $1.9B | ||
| Q1 24 | $1.5B | $2.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $26.7M |
| Free Cash FlowOCF − Capex | $36.1M | $26.1M |
| FCF MarginFCF / Revenue | 10.0% | 14.2% |
| Capex IntensityCapex / Revenue | 7.7% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 5.46× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $161.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $26.7M | ||
| Q3 25 | $26.6M | $63.8M | ||
| Q2 25 | $21.1M | $32.3M | ||
| Q1 25 | $11.4M | $46.7M | ||
| Q4 24 | $64.2M | $43.8M | ||
| Q3 24 | $57.3M | $55.9M | ||
| Q2 24 | $50.2M | $40.7M | ||
| Q1 24 | $-36.2M | $50.4M |
| Q4 25 | $36.1M | $26.1M | ||
| Q3 25 | $66.0K | $63.3M | ||
| Q2 25 | $-7.2M | $31.4M | ||
| Q1 25 | $-22.6M | $40.8M | ||
| Q4 24 | $29.8M | $43.0M | ||
| Q3 24 | $26.8M | $55.5M | ||
| Q2 24 | $16.7M | $40.0M | ||
| Q1 24 | $-71.6M | $50.1M |
| Q4 25 | 10.0% | 14.2% | ||
| Q3 25 | 0.0% | 35.5% | ||
| Q2 25 | -1.7% | 18.2% | ||
| Q1 25 | -6.0% | 24.4% | ||
| Q4 24 | 9.1% | 25.4% | ||
| Q3 24 | 6.7% | 33.5% | ||
| Q2 24 | 3.7% | 24.9% | ||
| Q1 24 | -21.3% | 31.8% |
| Q4 25 | 7.7% | 0.3% | ||
| Q3 25 | 7.1% | 0.3% | ||
| Q2 25 | 6.9% | 0.6% | ||
| Q1 25 | 9.0% | 3.6% | ||
| Q4 24 | 10.4% | 0.4% | ||
| Q3 24 | 7.7% | 0.2% | ||
| Q2 24 | 7.4% | 0.4% | ||
| Q1 24 | 10.5% | 0.2% |
| Q4 25 | — | 5.46× | ||
| Q3 25 | — | 12.07× | ||
| Q2 25 | 0.67× | 3.90× | ||
| Q1 25 | 0.49× | 7.72× | ||
| Q4 24 | 182.29× | 0.78× | ||
| Q3 24 | 2.57× | 3.24× | ||
| Q2 24 | 1.29× | 0.53× | ||
| Q1 24 | — | 4.66× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
